2 hours ago
1
JHVEPhoto
Viatris (NASDAQ:VTRS) announced on Monday that the U.S. FDA has approved its Iron Sucrose Injection, USP, as a generic product targeting Venofer marketed by Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) in collaboration with Swiss biotech Vifor Pharma.
Accordingly, the intravenous iron replacement solution
English (US) ·